Rabeprazole suppresses gastric acid secretion by inhibiting the gastric H+/K+-ATPase at the secretory surface of the gastric parietal cell. Because this enzyme is regarded as the acid (proton) pump within the parietal cell, Rabeprazole has been characterized as a gastric proton-pump inhibitor.
Related products
-22%
Domperidone Maleate
-12%
Bisoprolol Hemifumarate
-15%
Kumudini Pharma Ltd.
-26%
Cefixime
-20%
Elemental Calcium + Vitamin D3 500 mg+200 IU
-13%
Flucloxacillin Sodium
-35%
Esomeprazole
-12%
Bisoprolol Hemifumarate